SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future

Jamil, E; Saleem, Z; Godman, BB; Ullah, M; Amir, A; Haseeb, A; Mayer, JC; Qamar, MU; Abuhussain, SSA (2025) Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future. Frontiers in Pharmacology, 16. p. 1600787. ISSN 1663-9812 https://doi.org/10.3389/fphar.2025.1600787
SGUL Authors: Godman, Brian Barr

[img] PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB)
[img] Microsoft Word (.docx) Accepted Version
Available under License Creative Commons Attribution.

Download (1MB)

Abstract

Introduction: Antimicrobial resistance (AMR) has become a global burden, with inappropriate antibiotic prescribing being an important contributing factor. Antibiotic prescribing guidelines play an important role in improving the quality of antibiotic use, provided they are evidence-based and regularly updated. As a result, they help reduce AMR, which is a critical challenge in low- and middle-income countries (LMICs). Consequently, the objective of this study was to evaluate local, national, and international antibiotic prescribing guidelines currently available—especially among LMICs—and previous challenges, in light of the recent publication of the WHO AWaRe book, which provides future direction. Methodology: Google Scholar and PubMed searches were complemented by searching official country websites to identify antibiotic prescribing guidelines, especially those concerning empiric treatment of bacterial infections, for this narrative review. Data were collected on the country of origin, income level, guideline title, year of publication, development methodology, issuing organization, target population, scope, and coverage. In addition, documentation on implementation strategies, compliance, monitoring of outcome measures, and any associated patient education or counseling efforts were reviewed to assess guideline utilization. Results/findings: A total of 181 guidelines were included, with the majority originating from high-income countries (109, 60.2%), followed by lower-middle-income (40, 22.1%), low-income (18, 9.9%), and upper-middle-income (14, 7.7%) countries. The GRADE methodology was used in only 20.4% of the sourced guidelines, predominantly in high-income countries. Patient education was often underemphasized, particularly in LMICs. The findings highlighted significant disparities in the development, adaptation, and implementation of guidelines across different WHO regions, confirming the previously noted lack of standardization and comprehensiveness in LMICs. Conclusion: Significant disparities exist in the availability, structure, and methodological rigor of antibiotic prescribing guidelines across countries with different income levels. Advancing the development and implementation of standardized, context-specific guidelines aligned with the WHO AWaRe framework—and supported by equity-focused reforms—can significantly strengthen antimicrobial stewardship and help address the public health challenge of AMR.

Item Type: Article
Additional Information: © 2025 Jamil, Saleem, Godman, Ullah, Amir, Haseeb, Meyer, Qamar and Almarzoky Abuhussain. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Keywords: Antibiotic Prescribing Guidelines, Antimicrobial Resistance, AWaRe classification, GRADE,, LMICs, Patient Counselling, WHO Regions
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Frontiers in Pharmacology
ISSN: 1663-9812
Publisher License: Creative Commons: Attribution 4.0
URI: https://openaccess.sgul.ac.uk/id/eprint/117610
Publisher's version: https://doi.org/10.3389/fphar.2025.1600787

Actions (login required)

Edit Item Edit Item